Research Article

Mitochondria-Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan-Cancer Multiomics Analysis to Breast Cancer Validation

Figure 1

Multiple databases revealing the differential transcriptome map and pathological stage of SLC25A32 in pan-cancer. (a) The GEPIA2.0 platform revealed differential mRNA levels of SLC25A32 in paired tissues of pan-cancer. (b) The TIMER2.0 database uncovered the mRNA expression levels of SLC25A32 in unpaired cancer and healthy tissues. (c) The UALCAN platform showed the differential level of SLC25A32 in the pan-cancer at the mRNA level. (d) The GEPIA2.0 platform analysis presented a significant correlation between SLC2532 and the pathological stages of ACC, KICH, KIRP, LUAD, and USC tumours. ; ; and .
(a)
(b)
(c)
(d)